R. Johnpulle

Responses to immune checkpoint inhibitors in nonagenarians

J. Sosman, Douglas B. Johnson, I. Puzanov, 2016, Oncoimmunology.

Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction

J. Sosman, Douglas B. Johnson, I. Puzanov, 2016, Journal of Immunotherapy for Cancer.

Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti‐PD‐1 antibodies

Douglas B. Johnson, L. Haydu, M. Millward, 2019, Pigment cell & melanoma research.

The Impact of Nonsteroidal Anti-Inflammatory Drugs, Beta Blockers, and Metformin on the Efficacy of Anti-PD-1 Therapy in Advanced Melanoma.

J. McQuade, Douglas B. Johnson, G. Long, 2019, The oncologist.

Molecular Targeted Therapy Approaches for BRAF Wild-Type Melanoma

J. Sosman, Douglas B. Johnson, R. Johnpulle, 2016, Current Oncology Reports.

Impact of Age on Outcomes with Immunotherapy for Patients with Melanoma.

A. Giobbie-Hurder, R. Sullivan, K. Flaherty, 2017, The oncologist.

Sequencing Treatment in BRAFV600 Mutant Melanoma: Anti-PD-1 Before and After BRAF Inhibition

R. Sullivan, J. Sosman, Douglas B. Johnson, 2017, Journal of immunotherapy.

Treatment of elderly patients with melanoma

Douglas B. Johnson, I. Puzanov, R. Johnpulle, 2016, memo - Magazine of European Medical Oncology.

Deep exploration of the immune infiltrate and outcome prediction in testicular cancer by quantitative multiplexed immunohistochemistry and gene expression profiling

J. Kim, W. Rathmell, J. Bordeaux, 2017, Oncoimmunology.

Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling.

D. K. Jung, A. Kassim, S. Paczesny, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Incidence, features and management of radionecrosis (RN) in melanoma patients (pts) treated with cerebral radiotherapy (RT) and anti-PD-1 antibodies (PD1).

Douglas B. Johnson, L. Haydu, M. Millward, 2017 .

The Impact of Nonsteroidal Anti-Inflammatory Drugs, Beta Blockers, and Metformin on the Efficacy of Anti-PD-1 Therapy in Advanced Melanoma.

J. McQuade, Douglas B. Johnson, G. Long, 2020 .